Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Anti-inflammatory drug therapy in asthma.

Rottier BL, Duiverman EJ.

Paediatr Respir Rev. 2009 Dec;10(4):214-9. doi: 10.1016/j.prrv.2009.06.007. Epub 2009 Sep 25. Review.

PMID:
19879512
2.

Corticosteroid-sparing options in the treatment of childhood asthma.

Helms PJ.

Drugs. 2000;59 Suppl 1:15-22; discussion 43-5. Review.

PMID:
10741878
4.

Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data.

Jones C, Santanello NC, Boccuzzi SJ, Wogen J, Strub P, Nelsen LM.

J Asthma. 2003 Feb;40(1):93-101.

PMID:
12699217
6.

The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.

Kopriva F, Dzubak P, Potesil J, Hajduch M.

J Asthma. 2009 May;46(4):366-70. doi: 10.1080/02770900902777767.

PMID:
19484671
7.

Role of leukotriene receptor antagonists in the management of pediatric asthma: an update.

Dumitru C, Chan SM, Turcanu V.

Paediatr Drugs. 2012 Oct 1;14(5):317-30. doi: 10.2165/11599930-000000000-00000. Review.

PMID:
22897162
8.

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

Chung KF, Caramori G, Adcock IM.

Eur J Clin Pharmacol. 2009 Sep;65(9):853-71. doi: 10.1007/s00228-009-0682-z. Epub 2009 Jun 26. Review.

PMID:
19557399
9.

Should preschool wheezers ever be treated with inhaled corticosteroids?

Saglani S, Wilson N, Bush A.

Semin Respir Crit Care Med. 2007 Jun;28(3):272-85. Review.

PMID:
17562497
12.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
13.

Adherence to anti-inflammatory treatment for asthma in clinical practice in France.

Latry P, Pinet M, Labat A, Magand JP, Peter C, Robinson P, Martin-Latry K, Molimard M.

Clin Ther. 2008;30 Spec No:1058-68. doi: 10.1016/j.clinthera.2008.06.011.

PMID:
18640480
14.

Review of recent results of montelukast use as a monotherapy in children with mild asthma.

Wahn U, Dass SB.

Clin Ther. 2008;30 Spec No:1026-35. doi: 10.1016/j.clinthera.2008.05.018. Review.

PMID:
18640477
15.
16.

Weighing the risks of treatment versus nontreatment in pediatric asthma.

Spahn JD, Covar RA.

Pediatr Clin North Am. 2003 Jun;50(3):677-95. Review.

PMID:
12877241
17.

Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.

Riccioni G, Bucciarelli T, Mancini B, Di Ilio E, Palumbo G, D'Orazio N.

Clin Ter. 2007 Jul-Aug;158(4):363-70. Review.

PMID:
17953289
18.
19.

[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].

Bartkowiak-Emeryk M, Breborowicz A, Emeryk A, Kulus M, Kurzawa R, Lis G, Mazurek H, Niedziela M.

Pol Merkur Lekarski. 2004;17 Suppl 2:5-10. Review. Polish.

PMID:
15688663
20.

Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?

Jartti T.

Eur J Pediatr. 2008 Jul;167(7):731-6. doi: 10.1007/s00431-007-0644-3. Epub 2008 Jan 24. Erratum in: Eur J Pediatr. 2008 Jul;167(7):737-8.

PMID:
18214538

Supplemental Content

Support Center